The United Kingdom promotes gene sequencing to treat cancer chemotherapy or retreat to the historical stage

Release date: 2014-08-13

The British government has recently launched a medical research project called the “100,000 Genome Project”, which aims to effectively identify genes that cause cancer and other difficult diseases by sequencing the genome. The local media commented that if this plan is successfully implemented and successful, it will be a major breakthrough in the medical field, and the future treatment of cancer will not have to be carried out through chemotherapy.

It is understood that the "100,000 Genome Project" needs to invest 300 million pounds, which will integrate a large amount of data from scientific research into the British public health system. The UK will participate in sequencing of 70,000 genomes in a total of 100,000 genomes. It can be said that the "100,000 Genome Project" is an "upgraded version" of the "Thousand People Genome Project" that was launched in the UK. The new "100,000 Genome Project" does not only sequence specific cancer genes for cancer patients, but rather "genome sequencing." Since May of this year, the UK has started research in hospitals such as London and Cambridge. Universities and research institutions across the UK are also assisting the British Ministry of Health in promoting this program. According to the report, the UK has completed 100 genome sequencing, which will reach more than 1,000 in the year and reach 10,000 in 2015. It will be completed in 2017.

Dr. Burns, a doctor at the Crawford Clinic in London, told this reporter that chemotherapy is still the main way to treat cancer, but the side effects are large, so it is necessary to find alternative therapies that are less harmful to the human body. Mapping genomic maps will help to find alternative treatments for cancer in the future, and proper mastery of genomic maps will also help diagnose, prevent and treat cancer and other difficult conditions.

The British "Daily Mail" reported that cancer gene sequencing has gained some benefits, and has now developed a number of drugs specifically for a specific type of cancer, such as Herceptin for breast cancer. The promotion and implementation of the new “100,000 Genome Project” is expected to further break through cancer research. If the plan can be fully implemented and achieved great success, chemotherapy will become a thing of the past. Some experts predict that after 20 years, chemotherapy will withdraw from the historical stage.

In order to strengthen international cooperation, raise funds and carry out technical cooperation, the British government has invited the US biotechnology company Illumina as the “priority cooperation unit” of the plan. The company's gene sequencing method has always been in the market leading position, with a wide range of influences. The “100,000 Genome Project” also promises to impose strict confidentiality measures on genetic data. Although the final research results will be made public, the personal information of each patient participating in the program will never be disclosed.

Source: Chinese Journal of Science

Probiotic

Probiotics are a class of active microorganisms that are beneficial to the host by colonizing the human body and changing the composition of the flora in a certain part of the host. By regulating the immune function of the host mucosa and system or by regulating the balance of intestinal flora, promoting nutrient absorption and maintaining intestinal health, resulting in the production of single microorganisms or mixed microorganisms with well-defined composition that are beneficial to health.

Probiotics,Probiotic Efficacy,Probiotic vitamins,Probiotic Health Supplements

YT(Xi'an) Biochem Co., Ltd. , https://www.ytnutra.com